Charcot-Marie-Tooth Disease — Research Summary
Printed from RareWays (rareways.com.au) on 26 July 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Diaphragm hypertrophy and spinal stress response accompany phrenic myelin defects in a murine model of Charcot-Marie-Tooth Disease Type 1E.
Bazick Hannah et al. — Experimental neurology (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42105803/
- 2.
Transcranial Motor-Evoked Potentials Provide More Reliable Intraoperative Neuromonitoring Than Somatosensory-Evoked Potentials in Charcot-Marie-Tooth Patients Undergoing Periacetabular Osteotomy for Hip Dysplasia.
Yang Michele L et al. — Journal of the Pediatric Orthopaedic Society of North America (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42291697/
- 3.
Early-onset neuroinflammation drives neurodegeneration caused by lysosomal PI(3,5)P
Wong Bridget et al. — Neurobiology of disease (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42242586/
- 4.
Molecular, cellular, and clinical aspects of myofibrillar myopathy caused by HSPB8 frameshift mutations.
Zhou Wenli et al. — Biochimica et biophysica acta. Molecular basis of disease (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41951012/
- 5.
Saposin B Deficiency With Neurologic and Hepatobiliary Involvement: Two Patients Expanding the Clinical Spectrum.
Yoldas Celik Merve et al. — Journal of child neurology (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41334784/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Recruiting — Michael Shy
https://clinicaltrials.gov/study/NCT01193075
- 2.
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Recruiting — University of Iowa
https://clinicaltrials.gov/study/NCT01193088
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth disease is a group of inherited conditions that damage the peripheral nerves, causing progressive muscle weakness and reduced sensation, particularly in the feet, legs, and hands. It is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 people worldwide. There is currently no cure, but research into gene therapies and other treatments is advancing rapidly.
Most Recent Research
Charcot-Marie-Tooth disease type 1E (CMT1E) is a rare, early-onset dysmyelinating neuropathy linked with point mutations in the peripheral myelin protein 22 (PMP22) gene. Respiratory problems are known to impact neuropathic patients, yet existing studies have not characterized this pathophysiology in corresponding animal models. Trembler J (TrJ) mice carry the same Leu16Pro amino acid substitution in the PMP22 protein that is present in families diagnosed with CMT1E. Utilizing electrophysiological, biochemical and morphological approaches, we examined critical sites of the lower respiratory system, including the diaphragm, phrenic nerve and cervical (C3-C6) region of the spinal cord in adult age-matched wild type (Wt) and heterozygous TrJ mice. In response to high-frequency stimulation of the presynaptic phrenic nerve, diaphragm muscle fibers of neuropathic mice exhibited similar rundown in the release of acetylcholine, but failed to maintain action potentials, suggesting a postsynaptic, muscle-derived deficit in neurotransmission. Although muscle fiber subtype numbers were unaffected in neuropathic mice, cross-sectional areas were enlarged in all fiber subtypes. Additionally, the ubiquitin-proteasome and autophagy pathways were upregulated in muscle, suggesting compensatory remodeling that occurred concurrently with, or because of, impaired neurotransmission. Analyses of phrenic nerve sections revealed highly significant (p < 0.0001) myelin defects, axonal atrophy, and astrogliosis, accompanied by stress granule formation within the grey matter of the cervical spinal cord. These findings identify profound structural and functional deficits of the respiratory system in TrJ mice modeling CMT1E and establish phrenic neuropathy as a mechanism underlying neuronal stress responses in the cervical spinal cord as well as postsynaptic diaphragm dysfunction.
Common Questions
What is Charcot-Marie-Tooth Disease?
Charcot-Marie-Tooth disease is a group of inherited conditions that damage the peripheral nerves, causing progressive muscle weakness and reduced sensation, particularly in the feet, legs, and hands. It is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 people worldwide. There is currently no cure, but research into gene therapies and other treatments is advancing rapidly.
How many clinical trials are available for Charcot-Marie-Tooth Disease?
RareWays currently indexes 84 clinical trials for Charcot-Marie-Tooth Disease, of which 29 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Charcot-Marie-Tooth Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Charcot-Marie-Tooth Disease.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.